You are here

BeiGene to Present at the 8th SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass. and BEIJING, China, Feb. 22, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the company will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY. The presentation is scheduled for 10:00 a.m. EST on Friday, March 1st, 2019.
Friday, February 22, 2019 - 07:00